Claudia Keller

Evaluation of¹¹C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk

Stefanie D. Krämer, Thomas Betzel, Linjing Mu et al. · Journal of Nuclear Medicine · 2017 · 51 citations · Full text

Medicine, Neuroscience, Pharmacology +17

5-(2-¹⁸F-Fluoroethoxy)-l-Tryptophan as a Substrate of System L Transport for Tumor Imaging by PET

Stefanie D. Krämer, Linjing Mu, Adrienne Müller et al. · Journal of Nuclear Medicine · 2012 · 50 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors

Luca Gobbi, Julian Kretz, Christoph Ullmer et al. · Journal of Medicinal Chemistry · 2020 · 50 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Preclinical evaluation and test–retest studies of [18F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5)

Selena Milicevic Sephton, Adrienne Müller Herde, Linjing Mu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 33 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +16

Preclinical Evaluation of Benzazepine-Based PET Radioligands (<i>R</i>)- and (<i>S</i>)-¹¹C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ₁-Receptor–Targeted PET Imaging

Adrienne Müller Herde, Stefanie D. Krämer, Jasmine Varisco et al. · Journal of Nuclear Medicine · 2019 · 32 citations · Full text

Medicine, Neuroscience, Pharmacology +17